|
FBXL15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.922200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.346200E-02 |
| Normal-vs-Stage2 |
1.534320E-02 |
| Normal-vs-Stage3 |
3.638200E-03 |
| Normal-vs-Stage4 |
1.542450E-02 |
| Stage1-vs-Stage2 |
4.010400E-01 |
| Stage1-vs-Stage3 |
1.354570E-01 |
| Stage1-vs-Stage4 |
2.813600E-01 |
| Stage2-vs-Stage3 |
8.142000E-01 |
| Stage2-vs-Stage4 |
6.267800E-01 |
| Stage3-vs-Stage4 |
7.289200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.914420E-02 |
| Normal-vs-AfricanAmerican |
2.745800E-01 |
| Normal-vs-Asian |
3.766600E-01 |
| Caucasian-vs-AfricanAmerican |
2.664400E-01 |
| Caucasian-vs-Asian |
7.740000E-01 |
| AfricanAmerican-vs-Asian |
5.683800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.459400E-03 |
| Normal-vs-Female |
3.257900E-02 |
| Male-vs-Female |
9.634400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.443600E-02 |
| Normal-vs-Extreme_Weight |
1.706800E-01 |
| Normal-vs-Obese |
1.040000E-02 |
| Normal-vs-Extreme_Obese |
6.574800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.857600E-01 |
| Normal_Weight-vs-Obese |
9.209400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.278400E-02 |
| Extreme_Weight-vs-Obese |
1.511380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.158200E-01 |
| Obese-vs-Extreme_Obese |
4.295900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.364800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.220000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.056810E-01 |
| Normal-vs-Age(81-100Yrs) |
6.619200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.161400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.393000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.199970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.528400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.981600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.974200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.142800E-01 |
| Normal-VS-Type2 PRCC |
3.92209999999782E-06 |
| Normal-VS-KIRP CIMP |
5.318600E-03 |
| Normal-VS-Unclassified PRCC |
3.597600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.87610000002003E-06 |
| Type1 PRCC-VS-KIRP CIMP |
6.294200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.667170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.041600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.225500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.489800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.755800E-02 |
| Normal-vs-N1 |
2.177300E-03 |
| Normal-vs-N2 |
3.4967000406283E-09 |
| N0-vs-N1 |
2.871600E-01 |
| N0-vs-N2 |
3.5416999999982E-05 |
| N1-vs-N2 |
3.679500E-02 |
|
|
